Meade TW, Mellows S., Brozovic M., et al. Haemostatics function and ischaemic heart disease: principal results of Northwick Park Heart Study. Lancet. 1986;2:533-537.
2.
Lane A., Green F., Scarabin PY, et al. Factor VII Arg/Gln 353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis. 1996;119:119-127.
3.
Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LEProspective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation . 1997;96: 1102-1108.
4.
Mannucci PMPolymorphisms in the factor VII gene and the risk of myocardial infarction . N Engl J Med. 2001;344:458-459.
5.
Atherosclerosis, Thrombosis, and Vascular Biology ItalianStudy Group.No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation. 2003;107:1117-1122.
6.
Campo G., Valgimigli M., Ferraresi P., et al. Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol. 2006;26:2800-2806.
7.
van 't Hooft FM, Silveira A., Tornvall P., et al. Two Common Functional Polymorphisms in the Promoter Region of the Coagulation Factor VII Gene Determining Plasma Factor VII Activity and Mass Concentration. Blood. 1999; 93:3432-3441.
8.
Marchetti G. , Patracchini P., Papacchini M., Ferrati M., Bernardi F.A polymorphism in the 5' region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet. 1993;90:575-576.
9.
Sabater-Lleal M., Martinez-Marchan E., Martinez-Sanchez E., et al. Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications. Haematologica . 2003;88:906-913.
10.
Bernardi F. , Marchetti G., Pinotti M., et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol. 1996;16:72-76.
11.
de Maat MP, Green F., de Knijff P., Jespersen J., Kluft C.Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997 ;17:1918-1923.
12.
Porreca E., Di Febbo C., di Castelnuovo A., et al. Association of factor VII levels with inflammatory parameters in hypercolesterolemic patients. Atherosclerosis. 2002;165:159-166.
13.
Sass C., Blanquart C., Morange PE, Pfister M., Visvikis-Siest S.Association between factor VII polymorphisms and blood pressure: the Stanislas Cohort. Hypertension. 2004;44:674-680.
14.
Heywood DM, Carter AM, Catto AJ, Bamford JM, Grant PJPolymorphisms of the factor VII gene and circulating FVII: C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke. 1997;28: 816-821.
15.
Mukherjee M. , Scully MF, Kakkar VV, Philippou H., Lane DA, Jewitt D.Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic action. Thromb Haemost. 1997;77:675-678.
Pinotti M., Bertolucci C., Portaluppi F., et al. Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler Thromb Vasc Biol. 2005; 25:646-649.
18.
Iacoviello L., Di Castelnuovo A., De Knijff P., et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med. 1998; 338:79-85.
19.
Girelli D., Russo C., Ferraresi P., et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med. 2000;343:774-780.
